Trial Profile
Phase I/IIB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy and Dose Escalation of RAD001 in Patients With Esophageal Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 19 Mar 2019
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Capecitabine; Carboplatin; Oxaliplatin
- Indications Adenocarcinoma; Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions
- 14 Mar 2019 Status changed from active, no longer recruiting to completed.
- 10 Mar 2018 Planned End Date changed from 1 May 2019 to 1 May 2020.
- 10 Mar 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.